News

Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL ...
Trial Data Presented at BSG Live’25 Confirms the Clinical Potential of Nebokitug as a First-in-Class Novel Treatment for PSC and Supports Advancement to Phase 3. Treatmen ...
Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...
Werewolf Therapeutics, Inc. (the 'Company” or 'Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...
To Bentley’s design centre, so new that the paint has barely dried, to experience something of a landmark: the conceptual ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
Samsung Electronics Co. introduced three new foldable smartphones in an effort to broaden mainstream appeal before Apple Inc.
Samsung opens pre-bookings for Galaxy Z 7 series. Sony WF-C710N earbuds launched. Amazfit Active 2 Square smartwatch. JBL ...
Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...
It was a bold gambit that used a strategy typically reserved for organized crime cases to prosecute a music legend for ...
There’s a lot that AI can’t do, but hype and misinformation are driving prospective students away from Computer Science.